Columnist Sam Kirton's birthday prompts reflection on his IPF and transplant journey. Like Phil Collins, he says, "Take a look at me now." ...

Suspecting that deconditioning might be contributing to his muscle soreness, columnist Kylene Henderson's husband, Donnie, is ...

Computer-based analyses of CT scans may help predict disease progression and track treatment response among people with PPF, per trial data.

Lower activity of a gene called ZNF331 may help identify obstructive sleep apnea in people with idiopathic pulmonary fibrosis, per a study.

What is Ofev for idiopathic pulmonary fibrosis? Ofev (nintedanib) is an approved oral therapy used to treat people with idiopathic pulmonary fibrosis (IPF) and related lung conditions. It is not a ...

What is Esbriet for idiopathic pulmonary fibrosis? Esbriet (pirfenidone) is an approved oral medication that’s used to slow the decline of lung function in people with idiopathic pulmonary fibrosis ...

Trevi Therapeutics plans to launch two pivotal Phase 3 clinical trials to continue testing Haduvio (nalbuphine extended-release) as a treatment for people with idiopathic pulmonary fibrosis (IPF) who ...

Taking oral dietary supplements of epigallocatechin-3-gallate (EGCG) — an antioxidant in green tea — may stop and reverse the pro-fibrotic (scarring) state of the lungs of people with idiopathic ...

AstraZeneca’s experimental oral therapy saracatinib — originally developed to treat certain cancers — was found to be at least as effective, and even superior to the approved therapies Ofev ...

There is currently no cure for pulmonary fibrosis (PF). However, medication and other treatment options can help improve patients’ quality of life, ease symptoms, and slow the disease’s progression.

Insilico Medicine will soon launch an early clinical trial in China to test an inhaled version of its therapy candidate rentosertib in healthy volunteers and people with idiopathic pulmonary fibrosis ...